Affiliation:
1. Universidad de Buenos Aires, Facultad de Ciencias Médicas, Institute of Cardiovascular Physiopathology
2. Universidad de Buenos Aires, IBIMOL UBA-CONICET)
Abstract
Abstract
Thioredoxin-1 (Trx1) has cardioprotective effects on ischemia/reperfusion (I/R) injury, although its role in ischemic postconditioning (PostC) in middle-aged mice is not understood. This study aimed to evaluate if combining two cardioprotective strategies, such as Trx1 overexpression and PostC, could exert a synergistic effect in reducing infarct size in middle-aged mice. Young or middle-aged wild-type mice (Wt), transgenic mice overexpressing Trx1, and dominant negative (DN-Trx1) mutant of Trx1 mice were used. Mice hearts were subjected to I/R or PostC protocol. Infarct size, hydrogen peroxide (H2O2) production, protein nitration, Trx1 activity, mitochondrial function, and Trx1, pAkt and pGSK3β expression were measured. PostC could not reduce infarct size even in the presence of Trx1 overexpression in middle-aged mice. This finding was accompanied by a lack of Akt and GSK3β phosphorylation, and Trx1 expression (in Wt group). Trx1 activity was diminished and H2O2 production and protein nitration were increased in middle age. The respiratory control rate dropped after I/R in Wt-Young and PostC restored this value, but not in middle-aged groups. Our results showed that Trx1 plays a key role in the PostC protection mechanism in young but not middle-aged mice, even in the presence of Trx1 overexpression.
Publisher
Research Square Platform LLC
Reference42 articles.
1. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part II: The aging heart in health: Links to heart disease;Lakatta EG;Circulation,2003
2. Aging-Induced biological changes and cardiovascular diseases;Fajemiroye JO;Biomed Res Int,2018
3. World HealthOrganization, World Health Organization (2020) : Deaths by Cause, Age, Sex, by Country and by Region, 2000–2019. Geneva,. Updated 2020. Accessed Jul 2022. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death
4. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) results. Institute for Health Metrics and Evaluation, Seattle, WA, USA. Updated 2020. Accessed Jul 2022.http://ghdx.healthdata.org/gbd-results-tool
5. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: update from the GBD 2019 study;Roth GA;J Am CollCardiol,2020